Intravenous immunoglobulin in the Guillain-Barre syndrome

Review: plasma exchange or intravenous immunoglobulin reduces disability in the Guillain-Barre syndrome.

M a i n r e s u l t s Plasma exchange: At 4 weeks, more patients who received plasma exchange than supportive care improved by ≥ 1 disability grade (Table). Mean improvement in disability grade was greater in the plasma exchange group than in the supportive care group (4 RCTs, n = 585) (weighted mean difference [WMD] −0.89, 95% CI −1.14 to −0.63). The number of patients still on a ventilator 4 ...

The Guillain-Barre' syndrome.

Guillain-Barre’ Syndrome: A Case Report

Background and Objectives: Guillain-Barre´ Syndrome (GBS) is an acute-onset, monophasic, immune-mediated polyneuropathy that often follows an antecedent infection. Special nutritional support has an important role in these patients. Methods: A 6 years old girl with GBS was admitted to PICU of Dr. Sheikh Children Hospital (Mashhad, Iran). Chief compliance for hospitalization was inability to w...

Guillain-barre Syndrome

A case report is presented of a 33-year-old woman who awoke with distal paresthesias, mild incoordination, and progressive weakness. Examination 3 days later demonstrated weakness of the extremities, which was greater in distal muscles than in proximal ones! mild facial weakness, distal vibratory loss, and areflexia. Electrodiagnostic studies provided evidence of an acquired demyelinating polyr...

Detection of Anti-Ganglioside Antibodies in Guillain-Barre Syndrome